Synapse

← Genetic Testing

Papers in Genetic Testing

Page 7 · newest first

  1. Prenatal Genotyping for the RhD Blood Group Antigen: Considerations in Developing an Accurate TestGenetic Testing · 2000
  2. Biallelic Discrimination Assays for the Three Common Ashkenazi Jewish Mutations and a Common Non-Jewish Mutation, in Tay-Sachs Disease, Using Fluorogenic TaqMan ProbesGenetic Testing · 2000
  3. The M34T Allele Variant of Connexin 26Genetic Testing · 2000
  4. Disclosure of Huntington's Disease to Family Members: The Dilemma of Known but Unknowing PartiesGenetic Testing · 2000
  5. The Founder Mutations in the BRCA1 , BRCA2 , and ATM Genes in Moroccan Jewish Women with Breast CancerGenetic Testing · 2000
  6. Delineation of the Spectrum of Wilson Disease Mutations in the Greek Population and the Identification of Six Novel MutationsGenetic Testing · 2000
  7. Impact of BRCA1 Testing on Women with Cancer: A Pilot StudyGenetic Testing · 2000
  8. Characterization of an Interstitial Deletion del(13)(q22q32) Using Microdissection and Sequential FISH and G-BandingGenetic Testing · 2000
  9. Molecular Diagnosis of and Carrier Screening for the Neuronal Ceroid LipofuscinosesGenetic Testing · 2000
  10. Tay-Sachs Disease Carrier Screening: A 21-Year ExperienceGenetic Testing · 2000
  11. Rapid Mutation Screening of Phenylketonuria by Polymerase Chain Reaction-Linked Restriction Enzyme Assay and Direct Sequence of the Phenylalanine Hydroxylase Gene: Clinical Application in Northern Japan and Northern ChinaGenetic Testing · 2000
  12. Lack of Association of ACE /Angiotensinogen Genotype with Renal Function in Autosomal Dominant Polycystic Kidney DiseaseGenetic Testing · 2000
  13. The Risk of Fragile X Premutation Expansion Is Lower in Carriers Detected by General Prenatal Screening Than in Carriers from Known Fragile X FamiliesGenetic Testing · 2000
  14. Apparently Unstable Normal FMR1 Alleles in Nine Developmentally Delayed Patients: Implications for Molecular Diagnosis of the Fragile X SyndromeGenetic Testing · 2000
  15. Case-Specific, Breakpoint-Spanning DNA Probes for Analysis of Single Interphase CellsGenetic Testing · 2000
  16. Early Detection of Genetic Hemochromatosis: Should All Young Adults Be Offered the Genetic Test?Genetic Testing · 2000
  17. Geography of HFE C282Y and H63D MutationsGenetic Testing · 2000
  18. Screening for Hemochromatosis in Routine Medical Care: An Evaluation of Mean Corpuscular Volume and Mean Corpuscular HemoglobinGenetic Testing · 2000
  19. Transferrin Saturation Phenotype and HFE Genotype Screening for Hemochromatosis and Primary Iron Overload: Predictions from a Model Based on National, Racial, and Ethnic Group Composition in Central AlabamaGenetic Testing · 2000
  20. A Pilot C282Y Hemochromatosis Screening in Italian Newborns by TaqMan™ TechnologyGenetic Testing · 2000
  21. Large-Scale Screening for HFE Mutations: Methodology and CostGenetic Testing · 2000
  22. Detection of C282Y and H63D in the HFE GeneGenetic Testing · 2000
  23. Novel Method for Molecular Detection of the Two Common Hereditary Hemochromatosis MutationsGenetic Testing · 2000
  24. Population Screening for Hemochromatosis by PCR Using Sequence-Specific PrimersGenetic Testing · 2000
  25. A Reverse-Hybridization Assay for the Rapid and Simultaneous Detection of Nine HFE Gene MutationsGenetic Testing · 2000
  26. Identification of the Hin d III Polymorphic Site in the PAI-1 Gene: Analysis of the PAI-1 Hin d III Polymorphism by PCRGenetic Testing · 2000
  27. The Predictive Value of BRCA1 and BRCA2 Mutation TestingGenetic Testing · 2000
  28. Arrayed Primer Extension: Solid-Phase Four-Color DNA Resequencing and Mutation Detection TechnologyGenetic Testing · 2000
  29. Efficient Mutation Detection in Mismatch Repair Genes Using a Combination of Single-Strand Conformational Polymorphism and Heteroduplex Analysis at a Controlled TemperatureGenetic Testing · 2000
  30. Sensitivity of Multiple Color Spectral Karyotyping in Detecting Small Interchromosomal RearrangementsGenetic Testing · 2000
  31. Null Alleles at the Huntington Disease Locus: Implications for Diagnostics and CAG Repeat InstabilityGenetic Testing · 2000
  32. p53 Mutations, Polymorphisms, and Haplotypes in Pakistani Ethnic Groups and Breast Cancer PatientsGenetic Testing · 2000
  33. Support for the Availability of Prenatal Testing for Neurological and Psychiatric Conditions in the Psychiatric CommunityGenetic Testing · 1999
  34. Prenatal Diagnosis of Spinal Muscular Atrophy by Direct Molecular Analysis: Efficacy and Potential PitfallsGenetic Testing · 1999
  35. The Missing Link in Linkage Analysis: The Well Sibling RevisitedGenetic Testing · 1999
  36. Neural Tube Defect Prevalence in California (1990-1994): Eliciting Patterns by Type of Defect and Maternal Race/EthnicityGenetic Testing · 1999
  37. Various Mutation Screening Techniques in the DNA Mismatch Repair Genes hMSH2 and hMLH1Genetic Testing · 1999
  38. Mutations in Exon 3 of the PAH Gene Causing Mild HyperphenylalaninemiaGenetic Testing · 1999
  39. A 6-Year Experience Demonstrates the Utility of Screening for Both Cytogenetic and FMR-1 Abnormalities in Patients with Mental RetardationGenetic Testing · 1999
  40. Development of a Highly Accurate, Rapid PCR-RFLP Genotyping Assay for the Methylenetetrahydrofolate Reductase GeneGenetic Testing · 1999
  41. The Psychological Impact of Genetic Testing for Alzheimer DiseaseGenetic Testing · 1999
  42. Evidence from a Ghanaian Population of Known African Descent to Support the Proposition That Hemochromatosis Is a Caucasian DisorderGenetic Testing · 1999
  43. A Philosophical Critique of Decision Analysis as a Tool in Genetic TestingGenetic Testing · 1999
  44. Understanding Probabilistic Risk in Predisposition Genetic Testing for Alzheimer DiseaseGenetic Testing · 1999
  45. Evaluation of Genetic Tests: APOE Genotyping for the Diagnosis of Alzheimer DiseaseGenetic Testing · 1999
  46. The Genetics of Alzheimer Disease and the Application of Molecular TestsGenetic Testing · 1999
  47. Rapid F508del and F508C Assay Using Fluorescent Hybridization ProbesGenetic Testing · 1999
  48. Prepregnancy Testing for Single-Gene Disorders by Polar Body AnalysisGenetic Testing · 1999
  49. The Personal and Social Consequences of Alzheimer DiseaseGenetic Testing · 1999
  50. Meta-PCR: A Novel Method for Creating Chimeric DNA Molecules and Increasing the Productivity of Mutation Scanning TechniquesGenetic Testing · 1999